Home |
Free Dividend Report |
Stock Splits Calendar |
NERV Historical Stock Prices |
Preferred Stock Newsletter |
NERV Options Chain |
Stock Message Boards |
Minerva Neurosciences (NERV) has the following price history information. Looking back at NERV historical stock prices for the last five trading days, on April 22, 2024, NERV opened at $2.46, traded as high as $2.58 and as low as $2.44, and closed at $2.55. Trading volume was a total of 10.00K shares. On April 23, 2024, NERV opened at $2.59, traded as high as $2.59 and as low as $2.49, and closed at $2.53. Trading volume was a total of 4.60K shares. On April 24, 2024, NERV opened at $2.53, traded as high as $2.53 and as low as $2.47, and closed at $2.52. Trading volume was a total of 3.90K shares. On April 25, 2024, NERV opened at $2.50, traded as high as $2.50 and as low as $2.43, and closed at $2.43. Trading volume was a total of 5.80K shares. On April 26, 2024, NERV opened at $2.45, traded as high as $2.49 and as low as $2.43, and closed at $2.44. Trading volume was a total of 4.20K shares.
NERV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Minerva Neurosciences shares, starting with a $10,000 purchase of NERV, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 07/02/2014 | |
End date: | 04/26/2024 | |
Start price/share: | $48.00 | |
End price/share: | $2.44 | |
Dividends collected/share: | $0.00 | |
Total return: | -94.92% | |
Average Annual Total Return: | -26.17% | |
Starting investment: | $10,000.00 | |
Ending investment: | $507.50 | |
Years: | 9.82 |
NERV Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
04/22/2024 | $2.46 | $2.58 | $2.44 | $2.55 | 10.00K |
04/23/2024 | $2.59 | $2.59 | $2.49 | $2.53 | 4.60K |
04/24/2024 | $2.53 | $2.53 | $2.47 | $2.52 | 3.90K |
04/25/2024 | $2.50 | $2.50 | $2.43 | $2.43 | 5.80K |
04/26/2024 | $2.45 | $2.49 | $2.43 | $2.44 | 4.20K |
About Minerva Neurosciences |
Minerva Neurosciences is a clinical-stage biopharmaceutical company focused on the development and commercialization of product candidates to treat patients suffering from central nervous system diseases. Co.'s primary product candidate is roluperidone, a compound it is developing for the treatment of negative symptoms in patients with schizophrenia. Co. holds the license to roluperidone from Mitsubishi Tanabe Pharma Corporation with the rights to develop, sell and import roluperidone globally, excluding most of Asia. Co. also has exclusive rights to develop and commercialize MIN-301, a compound for the treatment of Parkinson's disease. |
NERV Historical Closing Prices | |
Date | Close |
04/22/2024 | $2.55 |
04/23/2024 | $2.53 |
04/24/2024 | $2.52 |
04/25/2024 | $2.43 |
04/26/2024 | $2.44 |
Healthcare Historical Prices |
NERV is categorized under the Healthcare sector; below are some other companies in the same sector:
NEUE Historical Stock Prices Also explore: NERV shares outstanding history
Free NERV Email Alerts:
|
NERV Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.